Risk of Serious Cardiovascular Problems with Medications for Attention-Deficit Hyperactivity Disorder

Overview of attention for article published in CNS Drugs, November 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 1 news outlet
policy: 2 policy sources

twitter: 7 X users

Citations

dimensions_citation: 112 Dimensions

Readers on

mendeley: 220 Mendeley
citeulike: 2 CiteULike

Summary News Policy documents X Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Guanfacine hydrochloride

Cited by Canadian Agency for Drugs and Technologies in Health on 17 Dec 2015

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Attention deficit hyperactivity disorder: diagnosis and management : Evidence update

Cited by National Institute for Health and Care Excellence on 18 Nov 2014

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.